FDA clears Ranbaxy generic for respiratory infections

12/14/2006 | Financial Express (India), The

The U.S. FDA has cleared Cefprozil tablets, a generic drug made by India's Ranbaxy Laboratories Ltd., for treating infections due to tonsillitis, sinusitis and bronchitis. A Ranbaxy official said the firm expects to have its version on the market early in 2007, in time to be available at the height of the season for respiratory complaints.

View Full Article in:

Financial Express (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ